Stewart et al., 2020 - Google Patents
Perspective: Nanoparticle-Mediated Delivery of Cryoprotectants For CryopreservationStewart et al., 2020
View HTML- Document ID
- 10488591235122820850
- Author
- Stewart S
- Arminan A
- He X
- Publication year
- Publication venue
- CryoLetters
External Links
Snippet
Nanotechnology research has continued to garner interest and is investigated across a number of fields and industries, ranging from water treatment to clinical and biomedical applications. In biomedical research, for example, polymeric nanoparticles can be leveraged …
- 239000002105 nanoparticle 0 title abstract description 80
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6978644B2 (en) | Antifreeze agents, antifreeze and cryopreservation compositions, their use and cryopreservation methods | |
Ma et al. | Advanced biomaterials in cell preservation: Hypothermic preservation and cryopreservation | |
CN106538512B (en) | A kind of active stem cell gel preparation of holding freeze-stored cell and its application | |
CN108207930B (en) | Cocktail type cryoprotectant and application thereof | |
Liu et al. | Dual suppression effect of magnetic induction heating and microencapsulation on ice crystallization enables low-cryoprotectant vitrification of stem cell–alginate hydrogel constructs | |
Cheng et al. | Cold‐responsive nanocapsules enable the sole‐cryoprotectant‐trehalose cryopreservation of β cell–laden hydrogels for diabetes treatment | |
Karow Jr | Cryoprotectants–a new class of drugs | |
CA2745539C (en) | Cellular compositions for use in therapy | |
Stolzing et al. | Hydroxyethylstarch in cryopreservation–Mechanisms, benefits and problems | |
CN103037847B (en) | For the preparation of the method for dry, stable hemostatic composition | |
JP2009247276A (en) | Thawed organ or tissue or thawed cell group to be donated, transplanted, added, or administered to living body, method for producing the same, and supercooled solution used therefor, and production apparatus for the same | |
CN102917691A (en) | Process for making dry and stable hemostatic compositions | |
Stewart et al. | Perspective: Nanoparticle-Mediated Delivery of Cryoprotectants For Cryopreservation | |
FR3038324A1 (en) | METHOD FOR CRYOPRESERVATION OF THERAPEUTICALLY TARGED CELLS | |
Yao et al. | Nanoparticle‐mediated intracellular protection of natural killer cells avoids cryoinjury and retains potent antitumor functions | |
Yao et al. | Cryopreservation of NK and T cells without DMSO for adoptive cell-based immunotherapy | |
Huang et al. | Advanced nanomaterials-assisted cell cryopreservation: a mini review | |
Xu et al. | Hydrogel-based cardiac repair and regeneration function in the treatment of myocardial infarction | |
CN109232995A (en) | The temperature-sensitive hydrogel of adjustable response temperature contains cell material and the preparation method and application thereof | |
Crowe et al. | Stabilization of cells during freeze-drying: the trehalose myth | |
Liu et al. | An autophagy-inhibitory MOF nanoreactor for tumor-targeted synergistic therapy | |
CN115005199A (en) | Cryopreservation solution and cryopreservation method for natural killer cells and application of cryopreservation solution and cryopreservation method | |
Matsumura et al. | 7 Cell and Materials Interface in Cryobiology and Cryoprotection | |
Kim et al. | Cryopreservation of engineered tissues and organoids | |
FR3038325A1 (en) | METHOD FOR CRYOPRESERVATION OF THERAPEUTICALLY TARGED CELLS |